Article
Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy.
Stem cell research - 1 May 2021
Liu Lichao, Shenoy Sushma P, Jahng James W S, Liu Yu, Knowles Joshua W, Zhuge Yan, Wu Joseph C
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is an inherited heart disease that can cause sudden cardiac death and heart failure. HCM often arises from mutations in sarcomeric genes, among which the MYBPC3 is the most frequently mutated. Here we generated two human induced pluripotent stem cell (iPSC) lines from a HCM patient who has a familial history of HCM and his daughter who carries the pathogenic non-coding mutation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
